Learn More
Medchemexpress LLC Midostaurin | 120685-11-2 | 99.81% | 570.64 | 50 MG

Supplier: Medchemexpress LLC 50MGHY10230
Midostaurin (PKC412; CGP 41251) is an orally active, reversible multi-targeted protein kinase inhibitor. It inhibits PKCα/β/γ, Syk, Flk-1, Akt, PKA, c-Kit, c-Fgr, c-Src, FLT3, PDFRβ, and VEGFR1/2 with IC50s ranging from 22-500 nM. Midostaurin also upregulates endothelial nitric oxide synthase (eNOS) gene expression and demonstrates powerful anticancer effects. It is intended for research use only.
- Orally active and reversible
- Multi-targeted protein kinase inhibitor
- Up-regulates endothelial nitric oxide synthase (eNOS) gene expression
- Demonstrates powerful anticancer effects
- Used for research and analytical applications
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.